Email: info@BSBortho.com
When most people think about PRP, they focus on “concentration” — how many times above baseline the platelets are. But concentration alone does not tell the full story.
Platelet dose is defined as:
In other words, it reflects the total number of platelets delivered to the tissue.
This distinction is critical. A small volume of highly concentrated PRP may deliver fewer total platelets than a larger volume of moderately concentrated PRP.
The literature increasingly supports the idea total platelet dose — not concentration — drives outcomes .
Recent evidence suggests a minimum therapeutic threshold.
Corsini et al. (2025) describe that intra-articular PRP treatments exceeding 3.5 billion platelets per injection, with cumulative doses of 10–12 billion platelets across multiple treatments, are associated with superior outcomes. Similarly, Berrigan et al. performed a systematic review of randomized trials in knee osteoarthritis and found that studies reporting positive outcomes had significantly higher platelet doses. The average platelet dose in studies with positive outcomes was approximately 5.5 billion platelets, compared to roughly 2.3 billion platelets in studies without benefit .
Why might this matter biologically? Platelets release a complex array of growth factors and signaling molecules, which regulate angiogenesis, cell migration, collagen synthesis, and immunomodulation. If the delivered dose is insufficient, the biologic stimulus may not reach a therapeutic threshold.
Interestingly, the answer may not be “the higher the better.”
In our 2025 meta-analysis by Hopper et al (2025), examining platelet-rich plasma for knee osteoarthritis, we found that compared with hyaluronic acid, PRP formulations delivering 5 and 10 billion total platelets were associated with the greatest improvements in functional outcomes.
This suggests the possibility of a dose-response curve, rather than a simple linear relationship.
PRP is not simply “platelets in plasma.” It is a complex biologic formulation. Platelets contain alpha granules packed with growth factors that influence tissue repair, inflammation, and vascular formation.
One of the key processes influenced by PRP is angiogenesis — the formation of new blood vessels — which is essential for tissue repair and regeneration. Everts et al. (2023) emphasize that platelet dosing and bioformulation strategies are central to initiating angiogenic cascades and restoring microvascular networks in chronically degenerative tissues .
Delivering an adequate platelet dose is important in shifting the injured tissue toward repair by:
Without adequate platelet numbers, these processes may not be sufficiently activated.
One of the largest problems in PRP research is heterogeneity. Over 40–50 commercial PRP systems exist, each producing different platelet concentrations, leukocyte compositions, and volumes .Unfortunately, many clinical trials historically failed to report platelet counts or total dose, making it difficult to compare studies. In fact, methodological inconsistencies in PRP reporting have been well documented .
As a result, two injections labeled “PRP” may differ dramatically in:
These differences likely contribute to inconsistent outcomes across studies.
Based on current literature:
PRP should be approached like pharmacology. We would never administer a medication without knowing the dose. The same principle applies here.
Platelet dosing refers to the total number of platelets delivered in a PRP injection, not just the concentration. It is one of the most important factors determining how effective platelet-rich plasma (PRP) therapy will be for healing tissues like tendons, ligaments, and joints.
Platelets contain growth factors that drive healing. A higher platelet dose means:
Research shows that higher platelet doses are associated with improved pain relief and function, particularly in conditions like knee osteoarthritis.
Two PRP injections can have the same concentration but very different total doses depending on volume. Total dose is often more clinically meaningful.
Yes. Evidence suggests:
However, optimal dosing strategies for different joints and conditions are still unknown.
No—there is significant variability:
Studies show large variability in PRP composition even within the same patient.
Yes. Measuring PRP composition helps ensure:
Without measurement, it is impossible to know whether the injection is delivering a therapeutic dose.
Ask:
These answers help determine whether you are receiving a high-quality, properly dosed treatment.
No. One of the biggest challenges in PRP research is the
This variability may be a major reason why PRP results can differ between providers and studies.
Increasingly, research suggests:
This is why understanding dose, not just “getting PRP,” is critical.
Berrigan WA, Bailowitz Z, Park A, Reddy A, Liu R, Lansdown D. A Greater Platelet Dose May Yield Better Clinical Outcomes for Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Systematic Review. Arthroscopy. 2025 Mar;41(3):809-817.e2.
Corsini A, Perticarini L, Palermi S, Bettinsoli P, Marchini A. Re-Evaluating Platelet-Rich Plasma Dosing Strategies in Sports Medicine: The Role of the "10 Billion Platelet Dose" in Optimizing Therapeutic Outcomes-A Narrative Review. J Clin Med. 2025 Apr 15;14(8):2714.
Everts PA, Lana JF, Onishi K, Buford D, Peng J, Mahmood A, Fonseca LF, van Zundert A, Podesta L. Angiogenesis and Tissue Repair Depend on Platelet Dosing and Bioformulation Strategies Following Orthobiological Platelet-Rich Plasma Procedures: A Narrative Review. Biomedicines. 2023 Jul 6;11(7):1922.
Hooper N, Shapiro S, Paidsetty V, Azarpey A, Jindal A, Mautner K, Easley K, Buford D, Sussman W, Jayaram P. Platelet-rich plasma outcomes in knee osteoarthritis are associated with the amount of total deliverable platelets: A systematic review and meta-analysis. PM R. 2026 Feb;18(2):210-222.
Ultrasound-guided tendon scraping is an emerging minimally invasive treatment for patellar tendinitis (jumper’s knee). A recent study shows promising results with faster return to sport and significant pain relief,
Read MorePatellar tendinitis (“jumper’s knee”) is a common cause of knee pain in athletes. Learn what causes it, why it lingers, and how advanced treatments like ultrasound-guided tendon scraping may help you recover faster and
Read More